Maternal Gestational Diabetes Mellitus and Newborn DNA Methylation: Findings From the Pregnancy and Childhood Epigenetics Consortium
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Maternal gestational diabetes mellitus (GDM) has been associated with adverse outcomes in the offspring. Growing evidence suggests that the epigenome may play a role, but most previous studies have been small and adjusted for few covariates. The current study meta-analyzed the association between maternal GDM and cord blood DNA methylation in the Pregnancy and Childhood Epigenetics (PACE) consortium. RESEARCH DESIGN AND METHODS: Seven pregnancy cohorts (3,677 mother-newborn pairs [317 with GDM]) contributed results from epigenome-wide association studies, using DNA methylation data acquired by the Infinium HumanMethylation450 BeadChip array. Associations between GDM and DNA methylation were examined using robust linear regression, with adjustment for potential confounders. Fixed-effects meta-analyses were performed using METAL. Differentially methylated regions (DMRs) were identified by taking the intersection of results obtained using two regional approaches: comb-p and DMRcate. RESULTS: Two DMRs were identified by both comb-p and DMRcate. Both regions were hypomethylated in newborns exposed to GDM in utero compared with control subjects. One DMR (chr 1: 248100345–248100614) was located in the OR2L13 promoter, and the other (chr 10: 135341870–135342620) was located in the gene body of CYP2E1. Individual CpG analyses did not reveal any differentially methylated loci based on a false discovery rate–adjusted P value threshold of 0.05. CONCLUSIONS: Maternal GDM was associated with lower cord blood methylation levels within two regions, including the promoter of OR2L13, a gene associated with autism spectrum disorder, and the gene body of CYP2E1, which is upregulated in type 1 and type 2 diabetes. Future studies are needed to understand whether these associations are causal and possible health consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888 · cited 1×
“In contrast, some European countries have adopted the International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines (21), which recommend a one-step approach, in which a 75-g 2-h OGTT is performed for all women at 24–28 weeks’ gestation.”
BackgroundAccounting for cellular heterogeneity is critical in epigenome-wide association studies
Jaffe, A. E., & Irizarry, R. A. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r31 · Cited by 1,067 · cited 1×
“In particular, few studies have adjusted for cell heterogeneity, an important source of variability in DNA methylation (31).”
BackgroundSacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1641 · Cited by 687
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.130415 · Cited by 577 · cited 1×
“ranging from 2% to 25% depending on the screening and diagnostic criteria used and the population examined (1,2).”
BackgroundComb-p: software for combining, analyzing, grouping and correcting spatially correlated P -values
Pedersen, B. S., Schwartz, D. A., Yang, I. V., & Kechris, K. J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts545 · Cited by 485
Clausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., Schmidt, L., & Damm, P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0305 · Cited by 453
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2905 · Cited by 223
The interrelationship between ethnicity and obesity on obstetric outcomes
Ramos, G. A., & Caughey, A. B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.06.040 · Cited by 119 · cited 1×
“risk factor for GDM (35) and may impact cord blood DNA methylation (36).”
BackgroundWan, H., Zhang, C., Li, H., Luan, S., & Liu, C. (2018) · Medicine · doi:10.1097/md.0000000000009438 · Cited by 105 · cited 6×
“However, cord blood DNA methylation has been associated with several outcomes that have been associated with in utero exposure to GDM, such as early childhood weight andadiposity (37)andASD (38).”
BackgroundInfluential
Cited by
Pathophysiology from preconception, during pregnancy, and beyond.
Hivert, M.-F., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C. J. D., Meek, C. L., Nolan, C. J., Ram, U., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00827-4 · Cited by 186
Self-citationSteenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Biological pathways associated with vitamins in autism spectrum disorder
Gusso, D., Prauchner, G. R. K., Rieder, A. S., & Wyse, A. T. S. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00674-z · Cited by 10
Hjort, L., Bredgaard, S. S., Manitta, E., Marques, I., Sørensen, A. E., Martino, D., Grunnet, L. G., Kelstrup, L., Houshmand-Oeregaard, A., Clausen, T. D., et al. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01673-3 · Cited by 6
“For 190 (74 O-GDM, 64 O-T1D, 52 O-BP) of the 206 adult offspring participants, genotyping data from peripheral blood buffy coat DNA collected during the first follow-up study [12] were available from a previously conducted genome-wide association study (GWAS) meta-analysis study [20].”
BackgroundResultInfluentialEpigenetic modifications and gestational diabetes mellitus
Prudente, S. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.1.3
Metadata
- Authors
- Howe, C. G., Cox, B., Fore, R., Jungius, J., Kvist, T., Lent, S., Miles, H. E., Salas, L. A., Rifas-Shiman, S., Starling, A. P., Yousefi, P., Ladd-Acosta, C., Baccarelli, A., Binder, E. B., Chatzi, V. L., Czamara, D., Dabelea, D., DeMeo, D. L., Ghantous, A., Herceg, Z., Kajantie, E., Lahti, J. M. T., Lawlor, D. A., Litonjua, A., Nawrot, T. S., Nohr, E. A., Oken, E., Pizzi, C., Plusquin, M., Räikkönen, K., Relton, C. L., Sharp, G. C., Sørensen, T. I. A., Sunyer, J., Vrijheid, M., Zhang, W., Hivert, M.-F., & Breton, C. V.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-10-10
- Volume
- 43
- Issue
- 1
- Pages
- 98-105
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2979921170
- Cited by
- 161
- References
- 13
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.